Nothing Special   »   [go: up one dir, main page]

Betts et al., 2007 - Google Patents

The impact of regulatory T cells on carcinogen-induced sarcogenesis

Betts et al., 2007

View HTML
Document ID
14876098610875771095
Author
Betts G
Twohig J
Van den Broek M
Sierro S
Godkin A
Gallimore A
Publication year
Publication venue
British journal of cancer

External Links

Snippet

Burnet proposed in the 1950's that the immune system is engaged in identifying and destroying abnormal cancerous cells. This process, termed immune surveillance, has been at the centre of intense debate for decades. Results using immunodeficient mice lend …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses

Similar Documents

Publication Publication Date Title
Betts et al. The impact of regulatory T cells on carcinogen-induced sarcogenesis
Ma et al. Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy
Perez-Ruiz et al. Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
Fabre et al. Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis
Yang et al. Differential roles of TNFα-TNFR1 and TNFα-TNFR2 in the differentiation and function of CD4+ Foxp3+ induced Treg cells in vitro and in vivo periphery in autoimmune diseases
Li et al. Regulatory T cells control toxicity in a humanized model of IL-2 therapy
Ermann et al. Nod/Ripk2 signaling in dendritic cells activates IL-17A–secreting innate lymphoid cells and drives colitis in T-bet−/−. Rag2−/−(TRUC) mice
Ji et al. MHC class I–restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8+ T cells
West et al. An intact immune system is required for the anticancer activities of histone deacetylase inhibitors
Walsh et al. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell–mediated autoimmunity
Deng et al. Extrafollicular CD4+ TB interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease
Qiu et al. Gpr174-deficient regulatory T cells decrease cytokine storm in septic mice
Yasuda et al. Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
Nishikii et al. DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease
O'Higgins et al. Deciphering the role of regulatory CD4 T cells in oral and oropharyngeal cancer: a systematic review
Yang et al. NKG2D+ CD4+ T cells kill regulatory T cells in a NKG2D-NKG2D ligand-dependent manner in systemic lupus erythematosus
Dahlhoff et al. Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression
Kim et al. CD160 serves as a negative regulator of NKT cells in acute hepatic injury
Idris et al. Increased regulatory T cells in acute lymphoblastic leukemia patients
Idris et al. Increased regulatory T cells in acute lymphoblastic leukaemia patients
Fujiwara et al. The GPR171 pathway suppresses T cell activation and limits antitumor immunity
Sang et al. Innate and adaptive signals enhance differentiation and expansion of dual-antibody autoreactive B cells in lupus
Guggino et al. Interleukin‐25 axis is involved in the pathogenesis of human primary and experimental murine Sjögren's syndrome
Hojo et al. Identification of a genomic enhancer that enforces proper apoptosis induction in thymic negative selection
Zinöcker et al. Kinetics of lymphocyte reconstitution after allogeneic bone marrow transplantation: markers of graft-versus-host disease